MADEDDU, Giordano
 Distribuzione geografica
Continente #
NA - Nord America 4.474
EU - Europa 3.455
AS - Asia 919
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 20
SA - Sud America 16
AF - Africa 12
Totale 8.920
Nazione #
US - Stati Uniti d'America 4.444
IT - Italia 1.421
UA - Ucraina 975
CN - Cina 774
DE - Germania 349
SE - Svezia 177
FR - Francia 156
FI - Finlandia 143
GB - Regno Unito 93
KR - Corea 30
RO - Romania 27
TR - Turchia 27
SG - Singapore 26
CA - Canada 25
BE - Belgio 24
AU - Australia 23
IN - India 17
EU - Europa 14
RU - Federazione Russa 14
BR - Brasile 13
PL - Polonia 12
IR - Iran 11
CH - Svizzera 9
NL - Olanda 8
ES - Italia 7
IE - Irlanda 6
JP - Giappone 6
SA - Arabia Saudita 6
A2 - ???statistics.table.value.countryCode.A2??? 5
BD - Bangladesh 5
BG - Bulgaria 5
LU - Lussemburgo 5
PT - Portogallo 5
HK - Hong Kong 4
HU - Ungheria 4
MD - Moldavia 4
MX - Messico 4
PH - Filippine 4
SK - Slovacchia (Repubblica Slovacca) 4
IL - Israele 3
NG - Nigeria 3
CL - Cile 2
MA - Marocco 2
MK - Macedonia 2
MZ - Mozambico 2
PK - Pakistan 2
RS - Serbia 2
TW - Taiwan 2
AL - Albania 1
AT - Austria 1
BT - Bhutan 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
ML - Mali 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PA - Panama 1
SL - Sierra Leone 1
TN - Tunisia 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZA - Sudafrica 1
ZM - Zambia 1
Totale 8.920
Città #
Chandler 1.265
Jacksonville 577
Princeton 396
New York 232
Nanjing 192
Dearborn 190
Wilmington 155
Sassari 141
Ann Arbor 106
Rome 105
Boardman 95
Nanchang 82
Shenyang 70
Beijing 68
Ashburn 62
Milan 50
Woodbridge 47
Tianjin 46
Hebei 43
Cagliari 39
Changsha 39
Jinan 35
Naples 29
Seoul 28
Jiaxing 26
Ningbo 26
Norwalk 25
Brussels 24
Zhengzhou 24
Andover 23
Kunming 21
Turin 21
Helsinki 20
Toronto 20
Falls Church 19
Guangzhou 19
Mountain View 19
Singapore 19
Taizhou 19
Izmir 18
San Francisco 18
Florence 15
Hangzhou 15
Auburn Hills 13
Changchun 12
Sydney 12
Bologna 11
Lanzhou 11
Genoa 10
Leawood 10
Los Angeles 10
Palermo 10
Ardabil 9
Brescia 9
Lappeenranta 9
San Mateo 9
Washington 9
Edinburgh 8
Gonnosfanàdiga 8
Verona 8
Alghero 7
Bari 7
Horia 7
Napoli 7
Ravenna 6
Augusta 5
Canberra 5
Città Di Castello 5
Cosenza 5
Dublin 5
Frankfurt am Main 5
Haikou 5
Hefei 5
Houston 5
Monza 5
São Bernardo do Campo 5
Catania 4
Cernusco sul Naviglio 4
Chisinau 4
Dallas 4
Iesi 4
London 4
Luxembourg 4
Novara 4
Padova 4
Paris 4
Pescara 4
Redwood City 4
Riyadh 4
Salzano 4
Seattle 4
Tappahannock 4
Torino 4
Trento 4
Venice 4
Amsterdam 3
Bolzano 3
Brunete 3
Budapest 3
Corridonia 3
Totale 4.831
Nome #
CASE REPORT: MIOCARDITE ACUTA DA CITOMEGALOVIRUS IN GIOVANE PAZIENTE IMMUNOCOMPETENTE 1.123
Enzyme biosensors for biomedical applications: Strategies for safeguarding analytical performances in biological fluids 104
Meningite linfomatosa in un paziente con linfoma plasmoblastico del cavo orale HIV-relato: ruolo della citarabina liposomiale. 88
Underserved populations and bacterial and protozoal sexually transmitted infections: a lost health-care opportunity 86
The burden of HIV-Associated neurocognitive disorder (HAND) in post-HAART era: Amultidisciplinary review of the literature 85
Alendronate reduces bone resorption in HIV-associated osteopenia/osteoporosis 83
Ebola virus disease: Case management in the Institute of Infectious Diseases, University Hospital of Sassari, Sardinia, Italy. 81
HEPATOCELLULAR CARCINOMA DEVELOPMENT IN A PATIENT WITH HCV INFECTION AFTER ERADICATION WITH DIRECT-ACTING ANTIVIRAL AGENTS 74
Targeted therapies in cholangiocarcinoma: emerging evidence from clinical trials 72
Tenofovir renal safety in HIV-infected patients: results from the SCOLTA Project 70
PARVOVIRUS B19 E POLIMIALGIA REUMATICA: THE BUTTERFLY EFFECT 69
Utilizzo di EVG/COBI/FTC/TDF in una paziente con viremia elevata e cirrosi HCV-correlata 68
Trends in the European HIV/AIDS epidemic: a perspective from Italy 65
The use of nucleoside reverse transcriptase inhibitors sparing regimens in treatment-experienced HIV-1 infected patients 64
Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis? 63
Kidney disease in HIV-infected patients. 62
Immune response induced by Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis peptides in current and past infectious mononucleosis: a risk for multiple sclerosis? 62
Natalizumab therapy modulates miR-155, miR-26a and proinflammatory cytokine expression in MS patients 62
Different impact of NNRTI and PI-including HAART on bone mineral density loss in HIV-infected patients 60
Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy 59
Active Case Finding for Communicable Diseases in Prison Settings: Increasing Testing Coverage and Uptake Among the Prison Population in the European Union/European Economic Area 59
Activation of endogenous retroviruses of the HERV-W family by Epstein Barr virus in vitro and in vivo: a dual virus model as the missing link with multiple sclerosis 58
Mucocutaneous leishmniasis as presentation of HIV infection in Sardinia, insular Italy 57
99mTc-tetrofosmin SPECT in solitary pulmonary nodule evaluation 57
Analisi delle Dual Therapy nei pazienti con HIV: Aspetti farmacoeconomici-epidemiologici e clinici 57
Somatostatin receptor scintigraphy with 111In-pentetreotide in non-functioning gastroenteropancreatic neuroendocrine tumors 56
Proteomic characterization of hepatitis C eradication: enzyme switch in the healing liver. 55
The usefulness of 99mTc-tetrofosmin SPECT in the detection of intrathoracic malignant lesions 55
The HIV treatment and care cascade in Italy: successes and disparities 55
Mediterranean spotted fever-like illness in Sardinia, Italy: a clinical and microbiological study 55
Mitochondrial toxicity and body shape changes during nucleos(t)ide analogues administration in patients with chronic hepatitis B 55
Editorial - Non AIDS-defining malignancies: a new epidemic in HIV-infected population for the upcoming decades? 54
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial. 54
Epidemiology, Clinical Aspects, Laboratory Diagnosis and Treatment of Rickettsial Diseases in the Mediterranean Area During COVID-19 Pandemic: A Review of the Literature 54
LPS and HIV gp120 modulate monocyte/macrophage CYP27B1 and CYP24A1 expression leading to vitamin D consumption and hypovitaminosis D in HIV-infected individuals. 54
The usefulness of 99mTc tetrofosmin scintigraphy in patients with breast cancer recurrences 53
Identifying HIV patients with an unfavorable cardiovascular risk profile in the clinical practice: results from the SIMONE study 53
Body fat changes in HIV patients on highly active antiretroviral therapy (HAART): a longitudinal DEXA study. 53
Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era 52
The additional role of 18F-FDG PET/CT in prosthetic valve endocarditis 52
The changing face of the HIV epidemic in Northern Sardinia: increased diagnoses among pregnant women 52
The monitoring and the management of adverse events: a new challenge in the treatment of HIV infection: results from a cohort study. 52
EFFICACIA A TOLLERABILITÀ DELLA DUAL THERAPY RALTEGRAVIR+DARUNAVIR/RITONAVIR NELLA PRATICA CLINICA 52
Rhino-maxillary and orbital mucormycosis in a patient with acute myeloid leukaemia:a successful surgery and antifungal therapy combined approach 52
The feature of Metabolic Syndrome in HIV naive patients is not the same of those treated: results from a prospective study. 51
Simplification to atazanavir/ritonavir+lamivudine in virologically suppressed HIV-infected patients: 24-weeks interim analysis from ATLAS-M trial. 51
Tache Noire in a Patient with Acute Q Fever 51
Pneumococcal pneumonia: clinical features, diagnosis and management in HIV-infected and HIV non infected patients 51
Drug-resistant disseminated polyclonal Mycobacterium avium complex in a patient with AIDS: a case report and review of the literature 51
COBI: I DATI DI EFFICACIA IN CO-FORMULAZIONE CON ELVITEGRAVIR 50
Myalgia and phosphokinase elevations in the HAART era: focus on Raltegravir. 50
Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study 50
Durability of lopinavir/ritonavir dual-therapies in individuals with viral load <50 copies/mL in the observational setting. 50
Arboviral infections in Egyptian and Sardinian children and adults with aseptic meningitis and meningo-encephalitis 49
Alexithymia Predicts Carotid Atherosclerosis, Vascular Events, and All-Cause Mortality in Human Immunodeficiency Virus-Infected Patients: An Italian Multisite Prospective Cohort Study 49
Body composition change in hiv-infected patients treated with HAART: a longitudinal DEXA study. 49
Acute respiratory distress syndrome due to influenza virus A/H1N1v in a patient with HIV/HCV co-infection 49
Somatostatin receptor scintigraphy in liver metastasis detection from gastroenteropancreatic neuroendocrine tumors 48
CD4 cell count and the risk of infective and non-infective serious non-AIDS events in HIV-positive persons seen for care in Italy. 48
Cytological and histological diagnosis of lung cancer in Sardinia and Italy in the 1990s 47
Usefulness of 99mTc-tetrofosmin scintigraphy in different variants of Kaposi's sarcoma. 47
DNMT1 modulation in chronic hepatitis B patients and hypothetic influence on mitochondrial DNA methylation status during long-term nucleo(t)side analogs therapy 47
Low High-density Lipoprotein Cholesterol (HDL) is Associated with the Risk of Non-AIDS Defining Malignancies 47
Body composition evaluation by DEXA in the follow up of HIV patients treted with HAART. 47
Longitudinal analysis of HIV-1 coreceptor tropism by single and triplicate HIV-1 RNA and DNA sequencing in patients undergoing successful first-line antiretroviral therapy 46
Body fat changes and mitochondrial alterations during HBV treatment: A warning for long term administration. 45
Objective evaluation of anosmia and ageusia in COVID-19 patients: Single-center experience on 72 cases 45
Clinical features, laboratory findings and predictors of death in hospitalized patients with COVID-19 in Sardinia, Italy 45
The De Ritis ratio as prognostic biomarker of in-hospital mortality in COVID-19 patients 45
Safety and durability in a cohort of HIV-1 positive patients treated with once and twice daily darunavir-based therapy (SCOLTA Project). 45
CAIDE risk score predicts atherosclerosis and vascular events in HIV patients. Preliminary data from the Italian multicentre cohort of CARdiovascular and late-life Dementia risk in HIV (CARDH) Study 45
Bacterial community-acquired pneumonia in HIV-infected patients 45
Tuberculosis Screening before Anti–Hepatitis C Virus Therapy in Prisons 44
Treatment with direct-acting antivirals in a multicenter cohort of HCV-infected inmates in Italy 44
QuantiFERON TB Gold: a new method for latent tuberculosis infection 44
Body fat changes in HIV patients on highly active antiretroviral therapy (HAART): a longitudinal DEXA study 43
Prevalence of Respiratory Symptoms and Screening for Chronic Obstructive Pulmonary Disease: Results from an Italian Multicenter Study 43
Time trend in hypertension prevalence, awareness, treatment, and control in a contemporary cohort of HIV-infected patients: the HIV and Hypertension Study 43
FATTORI ASSOCIATI A RIDUZIONE DELLE PRESTAZIONI MNESICHE IN UNA COORTE POLICENTRICA DI PAZIENTI CON INFEZIONE DA HIV. DATI PRELIMINARI DEL COGNITIVE SUBSTUDY: PROGETTO “ALESSITIMIA E RISCHIO CARDIOVASCOLARE IN HIV” 43
Co-administration of ritonavir-boosted protease inhibitors and rate of tenofovir discontinuation in clinical practice. 42
Lipid profile improvement in virologically suppressed hiv-1-infected patients switched to dolutegravir/ abacavir/lamivudine: Data from the SCOLTA project 42
Smoking habits in HIV-infected people compared with the general population in Italy: a cross-sectional study 42
HPV infection in HIV-positive females: the need for cervical cancer screening including HPV-DNA detection despite successful HAART 42
Hepatitis E virus and hepatitis A virus exposures in an apparently healthy high-risk population in Italy. 42
Hepatic echinococcosis: clinical and therapeutic aspects. 42
The usefulness of 99mTc-tetrofosmin SPECT in monitoring the response to chemotherapy in lung cancer patients 42
Adverse skin reactions in course of combined antiretroviral therapy 42
Body fat distribution changes and highly active antiretroviral therapy (HAART): a clinical study in HIV patients 42
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study 41
Heel quantitative ultrasound in HIV-infected patients: a cross-sectional study. 40
Efficacy and tolerability of dolutegravir and two nucleos(t)ide reverse transcriptase inhibitors in HIV-1-positive, virologically suppressed patients 40
Is metabolic syndrome associated to HIV infection per se? Results from the HERMES study 39
Bone safety of dolutegravir-containing regimens in people living with HIV: Results from a real-world cohort 39
Prevalence, awareness, treatment, and control rate of hypertension in HIV-infected patients: The HIV-HY study 39
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL 39
A longitudinal Study on body compositionin HIV –infected patients receiving HAART. 39
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA project 39
Rickettsia monacensis as Cause of Mediterranean Spotted Fever-like Illness, Italy 38
Efficacy and safety of switching to dolutegravir plus emtricitabine/tenofovir disoproxil fumarate (TDF) or elvitegravir/cobicistat/emtricitabine/TDF in virologically suppressed HIV-infected patients in clinical practice: results from a multicentre, observational study 38
Dalbavancin two dose regimen for the treatment of prosthetic joint infections: new possible options for difficult to treat infectious diseases 38
Totale 6.300
Categoria #
all - tutte 43.506
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.506


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019210 0 0 0 0 0 0 0 0 0 0 0 210
2019/20201.554 320 11 124 11 159 176 287 29 181 69 167 20
2020/20211.498 169 13 212 12 179 67 187 52 271 224 76 36
2021/20221.109 130 29 26 26 26 32 40 63 83 72 143 439
2022/20232.522 239 209 68 414 208 404 37 274 402 47 130 90
2023/20241.078 139 72 56 40 293 114 35 79 17 48 101 84
Totale 9.398